Why hypertension is the silent driver
Hypertension is the single largest modifiable risk factor for cardiovascular events worldwide. Untreated, it accelerates arteriosclerosis, raises the risk of myocardial infarction, stroke and renal failure, and stiffens the arterial walls so they can no longer dilate and constrict in response to demand.
Most cases are essential hypertension — meaning no specific underlying cause. Obesity, sedentary lifestyle, chronic stress, smoking, excess alcohol and a high-salt diet conspire with genetic predisposition to push blood pressure above 130/80. Once arteriosclerotic remodelling sets in, the body's natural blood pressure regulation degrades further, creating a feedback loop.
The six-month observation
In a CAM-practice observation, 13 patients with metabolic risk took 20 ml of Floradyle Essence Special Diet daily for six months. Mean systolic pressure dropped from 131 mmHg to 121 mmHg; diastolic from 74 to 69 mmHg. The size of the drop is comparable to what 20 minutes of brisk walking three times a week typically achieves.
Weight fell on average 4.6 kg, even though no formal dietary intervention was imposed. Subjective energy rose 55% and concentration 43% on the standardised questionnaire. A second cohort using Floradyle Essence Metabolic showed an even larger systolic drop — from 140 to 124 mmHg over the same period.
The mechanism: protect the vessel wall
Three mechanisms drive the cardiovascular effect. First, the polyphenol load — over 500 distinct polyphenolic compounds released during cascade fermentation — directly protects the vessel endothelium from oxidative damage. In an in-vitro LDL-oxidation model, addition of Floradyle Essence delayed the onset of LDL oxidation from 120 minutes to 344 minutes; combined with vitamin C, the lag phase extended to 432 minutes. Vitamin C alone, by contrast, was slightly pro-oxidative.
Second, oxidised LDL — the actual atherogenic form of cholesterol — is reduced. This matters more than total LDL, because it is oxidised LDL that triggers macrophage uptake, foam cell formation and plaque growth.
Third, levels of vanillylmandelic acid (the main metabolite of adrenaline and noradrenaline) returned to normal in nearly all participants. This points to a softening of stress-driven sympathetic nervous activity — a regulatory rather than a suppressive effect.
What it does not replace
Floradyle Essence is a food-based concentrate, not an antihypertensive medication. It is intended to support the body's regulatory systems alongside conventional care, not in place of it. Patients on prescription antihypertensives should continue them and monitor pressure regularly — dose reductions, where appropriate, should be made by the prescribing clinician.
- Open-label CAM-practice observation, n=13, 6 months, Floradyle scientific compendium
- Floradyle Essence Metabolic cohort, n=15, 6 months
- TUM Freising-Weihenstephan, in-vitro LDL oxidation model



